Fenofibric Acid Patent Expiration

1. Fibricor patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7569612 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

US7741373 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

US7741374 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)

US7915247 ATHENA Methods of use of fenofibric acid
Aug, 2027

(3 years from now)




Market Authorisation Date: 14 August, 2009

Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with elevated cholesterol and/or l...

Dosage: TABLET

More Information on Dosage

FIBRICOR family patents

Family Patents